# Ophthalmic and Topical Dosage Form New Animal Drugs; 2-Mercaptobenzothiazole Solution
> **Food and Drug Administration** · Final rule. · Published 2000-08-22 · Effective 2000-08-22 · 65 FR 50912
## Document
- **Document number:** 00-21414
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 65 FR 50912
- **CFR reference:** 21 CFR 524
- **Publication date:** 2000-08-22
- **Effective date:** 2000-08-22
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Combe, Inc. The supplemental NADA provides for the topical use of 2-mercaptobenzothiazole solution as an aid in the treatment of certain common skin inflammations in dogs.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2000/08/22/00-21414/ophthalmic-and-topical-dosage-form-new-animal-drugs-2-mercaptobenzothiazole-solution)
---
*AI Analytics · CC0 1.0*